American Vanguard (NYSE:AVD – Free Report) had its price target hoisted by Roth Mkm from $13.00 to $16.00 in a report published on Friday morning, Benzinga reports. The firm currently has a buy rating on the basic materials company’s stock.
Separately, Roth Capital reissued a buy rating on shares of American Vanguard in a research report on Wednesday, January 31st.
Check Out Our Latest Stock Analysis on American Vanguard
American Vanguard Stock Down 9.4 %
American Vanguard Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 10th. Investors of record on Wednesday, March 27th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date of this dividend is Tuesday, March 26th. American Vanguard’s dividend payout ratio is 44.45%.
Institutional Investors Weigh In On American Vanguard
Large investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC boosted its stake in shares of American Vanguard by 477.2% in the 1st quarter. Tower Research Capital LLC TRC now owns 1,166 shares of the basic materials company’s stock valued at $25,000 after purchasing an additional 964 shares in the last quarter. CWM LLC boosted its stake in shares of American Vanguard by 492.4% in the 4th quarter. CWM LLC now owns 2,340 shares of the basic materials company’s stock valued at $26,000 after purchasing an additional 1,945 shares in the last quarter. Captrust Financial Advisors boosted its stake in shares of American Vanguard by 85.0% in the 1st quarter. Captrust Financial Advisors now owns 1,417 shares of the basic materials company’s stock valued at $29,000 after purchasing an additional 651 shares in the last quarter. Point72 Middle East FZE acquired a new stake in shares of American Vanguard in the 4th quarter valued at approximately $31,000. Finally, Gladius Capital Management LP bought a new position in American Vanguard in the 4th quarter valued at approximately $37,000. 79.93% of the stock is currently owned by institutional investors and hedge funds.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Articles
- Five stocks we like better than American Vanguard
- The Significance of Brokerage Rankings in Stock Selection
- Insider Selling of Amazon Spikes in Q1, but it’s Not Time to Sell
- 3 Best Fintech Stocks for a Portfolio Boost
- 2 Deep Value, High Yield Stocks With a Double-Digit Upside
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Are We in a Bear Market? Here are the Signs
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.